Larry J. Anderson
#114,751
Most Influential Person Now
American virologist
Larry J. Anderson's AcademicInfluence.com Rankings
Larry J. Andersonbiology Degrees
Biology
#7006
World Rank
#9843
Historical Rank
Developmental Biology
#81
World Rank
#87
Historical Rank
Virology
#147
World Rank
#152
Historical Rank
Microbiology
#332
World Rank
#380
Historical Rank
Download Badge
Biology
Larry J. Anderson's Degrees
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Larry J. Anderson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Larry J. Anderson is an American virologist who served in leadership positions at the Centers for Disease Control and Prevention for more than three decades. He was director of the Division of Viral Diseases in the National Center for Immunization and Respiratory Diseases at the CDC , and chief of the Respiratory and Enteric Viruses Branch of the CDC Division of Viral and Rickettsial Diseases . From 2003 to 2006, Anderson led the CDC’s Post-Outbreak SARS Program, and he served as a special advisor on smallpox in the Office of the Associate Director for Terrorism, Preparedness, and Response.
Larry J. Anderson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A novel coronavirus associated with severe acute respiratory syndrome. (2003) (4084)
- MORTALITY ASSOCIATED WITH INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS IN THE UNITED STATES (2002) (3656)
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome (2003) (2442)
- Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus (2000) (1779)
- Bronchiolitis-associated hospitalizations among US children, 1980-1996. (1999) (1427)
- Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. (2004) (1155)
- Nipah virus: a recently emergent deadly paramyxovirus. (2000) (1138)
- A distinct lineage of influenza A virus from bats (2012) (1028)
- Morbidity and Mortality Weekly Report (2002) (674)
- Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. (2005) (662)
- Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. (2004) (610)
- Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. (1985) (604)
- Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. (2004) (580)
- Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. (2002) (565)
- Beyond viruses: clinical profiles and etiologies associated with encephalitis. (2006) (526)
- Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus (2001) (525)
- Human metapneumovirus infections in young and elderly adults. (2003) (518)
- Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. (2000) (513)
- Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. (2012) (501)
- Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. (2001) (488)
- Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. (2005) (431)
- Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. (1998) (424)
- Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. (1996) (423)
- CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein (2001) (420)
- In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. (2003) (385)
- Characterization of Human Metapneumoviruses Isolated from Patients in North America (2002) (372)
- Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern (1996) (353)
- Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. (1990) (329)
- Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. (2000) (299)
- Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006 (2012) (296)
- Prevalence of viral respiratory tract infections in children with asthma (2006) (294)
- Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus (2004) (291)
- Human Bocavirus: A Novel Parvovirus Epidemiologically Associated with Pneumonia Requiring Hospitalization in Thailand (2007) (290)
- Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. (1999) (290)
- Molecular characterization of Nipah virus, a newly emergent paramyxovirus. (2000) (288)
- Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. (2000) (274)
- Rhinovirus-Associated Hospitalizations in Young Children (2007) (266)
- Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay (1986) (262)
- Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2 (2008) (260)
- Human Metapneumovirus Infection among Children Hospitalized with Acute Respiratory Illness (2004) (248)
- Enterovirus 71 infections and neurologic disease--United States, 1977-1991. (1994) (245)
- Sensitive and Broadly Reactive Reverse Transcription-PCR Assays To Detect Novel Paramyxoviruses (2008) (241)
- Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. (1991) (227)
- The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). (1986) (225)
- Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. (1986) (224)
- Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses (1991) (218)
- Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. (2011) (217)
- Human-to-human transmission of rabies virus by corneal transplant. (1979) (210)
- Strategic priorities for respiratory syncytial virus (RSV) vaccine development (2013) (209)
- Guideline for Prevention of Nosocomial Pneumonia (1994) (207)
- Application of TaqMan Low-Density Arrays for Simultaneous Detection of Multiple Respiratory Pathogens (2011) (207)
- Identification of a Novel Astrovirus (Astrovirus VA1) Associated with an Outbreak of Acute Gastroenteritis (2009) (205)
- Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures (2020) (199)
- Rotavirus as a cause of diarrheal morbidity and mortality in the United States. (1988) (195)
- Severe Acute Respiratory Syndrome Coronavirus on Hospital Surfaces (2004) (194)
- Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. (1986) (193)
- Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). (2003) (193)
- Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya (2009) (192)
- Risk factors for bronchiolitis-associated deaths among infants in the United States (2003) (185)
- Viral respiratory infections in hospitalized and community control children in Alaska†, ‡ (2010) (182)
- National surveillance of Kawasaki disease. (1980) (182)
- Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. (1997) (182)
- Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. (1986) (181)
- Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. (2002) (181)
- Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments (1986) (180)
- Substantial variability in community respiratory syncytial virus season timing (2003) (179)
- Role of parvovirus B19 in human disease. (1987) (177)
- Kawasaki syndrome: description of two outbreaks in the United States. (1981) (171)
- Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. (2006) (171)
- SARS-coronavirus replication in human peripheral monocytes/macrophages (2004) (169)
- Analyses of homologous rotavirus infection in the mouse model. (1995) (169)
- Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). (1988) (166)
- Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. (1990) (161)
- Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice (1999) (161)
- Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. (1994) (161)
- Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies (1988) (151)
- Day-care center attendance and hospitalization for lower respiratory tract illness. (1988) (149)
- Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses (2006) (148)
- Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. (1990) (148)
- Simultaneous Detection and Identification of Human Parainfluenza Viruses 1, 2, and 3 from Clinical Samples by Multiplex PCR (1998) (147)
- Molecular Epidemiology of Adenovirus Type 7 in the United States, 1966–2000 (2002) (144)
- Clinical and epidemiologic features of respiratory syncytial virus. (2013) (143)
- Novel Human Rhinoviruses and Exacerbation of Asthma in Children (2008) (142)
- Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States (2001) (138)
- Severe Acute Respiratory Syndrome in Children (2007) (136)
- Diarrheal deaths in American children. Are they preventable? (1988) (135)
- Laboratory Diagnosis of Four Recent Sporadic Cases of Community-acquired SARS, Guangdong Province, China (2004) (134)
- Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. (2009) (131)
- Epidemiology and Prevention of Respiratory Syncytial Virus Infections Among Infants and Young Children (2011) (131)
- Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. (1988) (131)
- Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. (1984) (127)
- Multicenter study of strains of respiratory syncytial virus. (1991) (126)
- Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum (1991) (122)
- Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. (2009) (119)
- Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains☆ (2003) (118)
- GeneScan Reverse Transcription-PCR Assay for Detection of Six Common Respiratory Viruses in Young Children Hospitalized with Acute Respiratory Illness (2003) (118)
- Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. (1997) (117)
- Lower Respiratory Tract Infections Among American Indian and Alaska Native Children and the General Population of U.S. Children (2005) (115)
- Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay (1985) (115)
- Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. (1995) (113)
- Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P (2003) (112)
- A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. (1989) (111)
- Respiratory Syncytial Virus Hospitalizations Among American Indian and Alaska Native Infants and the General United States Infant Population (2004) (110)
- Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. (1993) (110)
- National surveillance for respiratory syncytial virus, United States, 1985-1990. (1994) (109)
- Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. (2000) (108)
- Nosocomial transmission of respiratory syncytial virus in immunocompromised adults (1991) (107)
- CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. (2015) (107)
- Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. (2008) (107)
- Clinical patterns and seasonal trends in respiratory syncytial virus hospitalizations in São Paulo, Brazil. (2001) (106)
- Update: multistate outbreak of mumps--United States, January 1-May 2, 2006. (2006) (104)
- Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates. (1996) (104)
- Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. (1999) (101)
- Risk factors for Nipah virus infection among abattoir workers in Singapore. (2000) (101)
- Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse (2000) (101)
- Protective and disease-enhancing immune responses to respiratory syncytial virus. (1995) (101)
- Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus (1991) (100)
- Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. (1979) (99)
- Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice (2009) (99)
- A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. (2001) (96)
- Analysis of respiratory syncytial virus genetic variability with amplified cDNAs (1993) (96)
- Human Parvovirus B19 Infection During Pregnancy (1987) (92)
- Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. (2002) (92)
- Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. (1990) (91)
- The G Glycoprotein of Respiratory Syncytial Virus Depresses Respiratory Rates through the CX3C Motif and Substance P (2003) (90)
- Variation in Timing of Respiratory Syncytial Virus Outbreaks: Lessons From National Surveillance (2007) (89)
- Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. (1992) (87)
- Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. (1994) (87)
- Real-Time Detection of Virus Particles and Viral Protein Expression with Two-Color Nanoparticle Probes (2005) (85)
- Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway (2008) (85)
- Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. (1996) (84)
- Respiratory Syncytial Virus Infection and G and/or SH Protein Expression Contribute to Substance P, Which Mediates Inflammation and Enhanced Pulmonary Disease in BALB/c Mice (2000) (83)
- Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses (2013) (83)
- Chronic parvovirus infection in a presumably immunologically healthy woman. (1992) (81)
- Viral Meningitis-Associated Hospitalizations in the United States, 1988–1999 (2003) (80)
- Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. (1994) (79)
- Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy. (2016) (77)
- Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. (2004) (76)
- Challenges and Opportunities for Respiratory Syncytial Virus Vaccines (2013) (76)
- Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV (1997) (73)
- Antigenic Analysis Of Current Wild Type And Vaccine Strains Of Measles Virus (1994) (72)
- Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. (1998) (70)
- Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay (1986) (70)
- Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation (2003) (69)
- Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay (1985) (69)
- Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. (1999) (69)
- Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice (2010) (69)
- Infectious disease hospitalizations among American Indian and Alaska native infants. (2003) (68)
- Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice. (2009) (68)
- Multiplex Assay for Detection of Strain-Specific Antibodies against the Two Variable Regions of the G Protein of Respiratory Syncytial Virus (2002) (68)
- Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. (2002) (67)
- CD40 Ligand (CD154) Enhances the Th1 and Antibody Responses to Respiratory Syncytial Virus in the BALB/c Mouse (2000) (67)
- Human parvovirus B19. (1989) (67)
- Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene (2016) (67)
- Outbreak of Pneumonia in a Long‐term Care Facility: Antecedent Human Parainfluenza Virus 1 Infection May Predispose to Bacterial Pneumonia (1998) (66)
- Nonclassic measles infections in an immune population exposed to measles during a college bus trip (1998) (66)
- Occupational Risk of Human Parvovirus B19 Infection for School and Day-Care Personnel during an Outbreak of Erythema Infectiosum (1990) (65)
- Severe acute respiratory syndrome: review and lessons of the 2003 outbreak (2004) (65)
- Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections (1989) (65)
- Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. (1989) (65)
- Antigenic and genomic diversity within group A respiratory syncytial virus. (1991) (64)
- Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile. (1996) (63)
- Diarrheal illness among infants and toddlers in day care centers: effects of active surveillance and staff training without subsequent monitoring. (1988) (63)
- Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins (2005) (60)
- Human parvovirus B19 and pregnancy. (1988) (60)
- Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. (2001) (60)
- Kawasaki Disease and Human Coronavirus (2005) (56)
- Severe Anemia Caused by Human Parvovirus in a Leukemia Patient on Maintenance Chemotherapy (1988) (55)
- Comparison of monoclonal time-resolved fluoroimmunoassay with monoclonal capture-biotinylated detector enzyme immunoassay for adenovirus antigen detection (1987) (55)
- Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. (1991) (55)
- Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy (2018) (55)
- Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk. (2016) (54)
- An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. (2015) (53)
- Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. (2003) (53)
- Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop. (2016) (53)
- Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy (2017) (52)
- Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection (1989) (52)
- The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography (2018) (51)
- The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. (2002) (51)
- SARS-associated Coronavirus Transmission, United States (2004) (50)
- Infant Viral Respiratory Infection Nasal Immune‐Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze (2018) (49)
- Foundations of the Severe Acute Respiratory Syndrome Preparedness and Response Plan for Healthcare Facilities (2004) (47)
- Severe Bronchiolitis and Respiratory Syncytial Virus Among Young Children in Hawaii (2007) (47)
- Norwalk virus antigen and antibody response in an adult volunteer study (1987) (47)
- Postexposure trial of a human diploid cell strain rabies vaccine. (1980) (47)
- Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura. (1996) (47)
- Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection (2002) (46)
- Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease (2013) (45)
- Possible transmission of parvovirus B19 from intravenous immune globulin (1997) (45)
- Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008. (2010) (45)
- Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. (1994) (45)
- Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery (2015) (44)
- Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective (2017) (44)
- Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice (2014) (44)
- Refractory Status Epilepticus in Suspect Encephalitis (2008) (43)
- Epidemic infections caused by respiratory syncytial virus in institutionalized young adults. (1987) (43)
- Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses. (1994) (42)
- Parvovirus B19 infection in hospital workers: community or hospital acquisition? (1995) (42)
- Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation. (1982) (42)
- Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. (1993) (41)
- Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study. (2004) (41)
- Aplastic crisis in sickle cell disorders: bone marrow necrosis and human parvovirus infection. (1988) (41)
- SARS Surveillance during Emergency Public Health Response, United States, March–July 2003 (2004) (41)
- Risk factors associated with echovirus 11' infection in a hospital nursery (1986) (41)
- Trends in encephalitis-associated deaths in the United States (2006) (41)
- Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE) (2015) (40)
- Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate (2000) (39)
- Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines. (2017) (39)
- Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures (2020) (38)
- Use of Respiratory Syncytial Virus Surveillance Data to Optimize the Timing of Immunoprophylaxis (2010) (37)
- Neutralizing Anti-F Glycoprotein and Anti-Substance P Antibody Treatment Effectively Reduces Infection and Inflammation Associated with Respiratory Syncytial Virus Infection (2002) (37)
- Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice (2012) (36)
- Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection. (1999) (35)
- Mumps Epidemiology and Immunity: The Anatomy of a Modern Epidemic (2008) (35)
- Emerging human coronaviruses--disease potential and preparedness. (2012) (35)
- Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wild-type strains of respiratory syncytial virus (1996) (35)
- Anti‐respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model (2018) (35)
- Respiratory syncytial virus activity - United States, July 2008-December 2009. (2010) (35)
- Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007. (2009) (34)
- Update on SARS research and other possibly zoonotic coronaviruses☆ (2010) (33)
- Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection☆ (2011) (33)
- Nosocomial Viral Infections (1988) (33)
- Serum immunoglobulin A response to Norwalk virus infection (1989) (32)
- Viral Respiratory Illnesses (1983) (32)
- Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology. (1990) (31)
- Community outbreak of thyrotoxicosis: epidemiology, immunogenetic characteristics, and long-term outcome. (1988) (31)
- Antigenic analysis of current wild type and vaccine strains of measles virus. (1995) (31)
- TH1- AND TH2-TYPE CYTOKINE EXPRESSION BY ACTIVATED T LYMPHOCYTES FROM THE LUNG AND SPLEEN DURING THE INFLAMMATORY RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS (2000) (31)
- Antigenic characterization of respiratory syncytial virus group A and B isolates in Rio de Janeiro, Brazil (1991) (30)
- Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA. (1996) (29)
- Application of proteomics methods for pathogen discovery☆ (2009) (28)
- Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development (2019) (28)
- CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice. (2003) (28)
- Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children (2015) (28)
- Genomic characterization of seven distinct bat coronaviruses in Kenya (2012) (28)
- Genetic variability of group A and B human respiratory syncytial viruses isolated from 3 provinces in China (2007) (26)
- Respiratory syncytial virus outbreak on American Samoa. Evaluation of risk factors. (1989) (26)
- Human Rhinovirus Induced Cytokine/Chemokine Responses in Human Airway Epithelial and Immune Cells (2014) (26)
- Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus. (1999) (26)
- Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing (2018) (25)
- Human Bocavirus: A New Viral Pathogen (2007) (24)
- A Vision-Based Respiration Monitoring System for Passive Airway Resistance Estimation (2016) (24)
- Comparison of a monoclonal antibody with a polyclonal serum in an enzyme-linked immunosorbent assay for detecting adenovirus (1983) (24)
- Risk of infection following exposures to human parvovirus B19. (1990) (24)
- A passive quantitative measurement of airway resistance using depth data (2014) (23)
- Differentiation of respiratory syncytial virus subgroups with cDNA probes in a nucleic acid hybridization assay (1990) (23)
- Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine (1998) (23)
- Molecular Detection of Adenoviruses, Rhabdoviruses, and Paramyxoviruses in Bats from Kenya (2014) (23)
- Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line (1991) (22)
- Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins (2007) (22)
- Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus (1990) (22)
- Annual Variation in Respiratory Syncytial Virus Season and Decisions Regarding Immunoprophylaxis With Palivizumab (2004) (22)
- The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection (2017) (22)
- TH(1)- and TH(2)-TYPE cytokine expression by activated t lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus. (2000) (22)
- The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein (2021) (21)
- Broadly Reactive Pan-Paramyxovirus Reverse Transcription Polymerase Chain Reaction and Sequence Analysis for the Detection of Canine Distemper Virus in a Case of Canine Meningoencephalitis of Unknown Etiology (2009) (21)
- A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response (2018) (21)
- Development and evaluation of an IgM capture enzyme immunoassay for diagnosis of recent Norwalk virus infection. (1989) (21)
- Antigenic and nucleic acid analysis of nosocomial isolates of respiratory syncytial virus. (1993) (20)
- Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice (2013) (20)
- Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004–2008 (2013) (19)
- Detection of respiratory syncytial virus defective genomes in nasal secretions is associated with distinct clinical outcomes (2021) (19)
- Respiratory syncytial virus vaccines for otitis media. (2000) (18)
- Response to Rhinovirus Infection by Human Airway Epithelial Cells and Peripheral Blood Mononuclear Cells in an In Vitro Two-Chamber Tissue Culture System (2013) (18)
- Rapid antibody response to human diploid rabies vaccine. (1981) (17)
- Respiratory syncytial virus vaccine development. (2013) (17)
- Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin. (2009) (17)
- Use of the biotin-avidin system to study the specificity of antibodies against respiratory syncytial virus (1984) (17)
- RESPIRATORY SYNCYTIAL VIRUS AND STAPHYLOCOCCUS AUREUS COINFECTION IN CHILDREN HOSPITALIZED WITH PNEUMONIA (2010) (17)
- Analysis of antigenically intermediate strains of subgenus B and D adenoviruses from AIDS patients (2005) (17)
- Identification of adenoviruses in fecal specimens from wild chimpanzees (Pan trogylodytes schweinfurthii) in western Tanzania. (2010) (17)
- CD4+ T Cell Frequencies and Th1/Th2 Cytokine Patterns Expressed in the Acute and Memory Response to Respiratory Syncytial Virus I-Ed-Restricted Peptides (2001) (16)
- Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence. (1984) (16)
- Clinical experience with a human diploid cell rabies vaccine. (1980) (16)
- Respiratory Syncytial Virus G and / or SH Protein Alters Th 1 Cytokines , Natural Killer Cells , and Neutrophils Responding to Pulmonary Infection in BALB / c Mice (1999) (16)
- An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant. (1989) (16)
- Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells (2019) (16)
- Major trends in nosocomial viral infections. (1991) (16)
- Nosocomial rabies: investigation of contacts of human rabies cases associated with a corneal transplant. (1984) (15)
- Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection (2021) (15)
- Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles. (2004) (15)
- Monoclonal Time-Resolved Fluoroimmunoassay: Sensitive Systems for the Rapid Diagnosis of Respiratory Virus Infections (1991) (14)
- Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assay. (2000) (13)
- Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection. (1992) (13)
- Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine. (2001) (13)
- Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43☆ (2011) (13)
- Quantification of respiratory syncytial virus polypeptides in nasal secretions by monoclonal antibodies. (1985) (13)
- Direct Sequencing of SARS-Coronavirus S and N Genes from Clinical Specimens Shows Limited Variation (2004) (13)
- Functional Features of the Respiratory Syncytial Virus G Protein (2021) (12)
- Decrease in Varicella Incidence After Implementation of the 2-dose Recommendation for Varicella Vaccine in New Hampshire (2013) (12)
- Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities. (1985) (12)
- Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine. (1997) (12)
- Urine Club Cell 16-kDa Secretory Protein and Childhood Wheezing Illnesses After Lower Respiratory Tract Infections in Infancy. (2015) (11)
- Neurotropic Viral Infections: Epidemiology of viral encephalitis (2008) (11)
- Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level (2021) (11)
- Human parvovirus B19. (1990) (11)
- Respiratory Syncytial Virus G Protein and G Protein CX 3 C Motif Adversely Affect CX 3 CR 1 T Cell Responses (2006) (10)
- CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides. (2001) (10)
- Prophylaxis for persons in contact with patients who have rabies. (1980) (9)
- MUC5AC Levels Associated With Respiratory Syncytial Virus Disease Severity (2018) (9)
- Coronavirus Antibodies in Bat Biologists (2008) (9)
- Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015 (2018) (9)
- Spectrophotometric quantitation of peroxidase-stained protein bands following gel electrophoresis and the western blot transfer technique with respiratory syncytial virus. (1984) (9)
- Detection of enterovirus 70 with monoclonal antibodies (1984) (9)
- RSV Strains and Disease Severity. (2018) (9)
- Aqueous quaternary ammonium compounds and rabies treatment. (1979) (9)
- Human parvovirus B19 infection during pregnancy. (1988) (8)
- Diagnosis of enterovirus 70 infection by demonstration of IgM antibodies (1987) (8)
- CX3CR1 Engagement by Respiratory Syncytial Virus Leads to Induction of Nucleolin and Dysregulation of Cilium-Related Genes (2021) (8)
- Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia (1997) (7)
- Treatment and Prevention of Human Parvovirus B19 Disease (1997) (7)
- Increasing Rate of Pneumonia Hospitalizations among Older American Indian and Alaska Native Adults (2008) (7)
- Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infection (2020) (6)
- In vitro model for the assessment of human immune responses to subunit RSV vaccines (2020) (6)
- The Pet in the Military Family at Transfer Time (1985) (6)
- Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. (2017) (6)
- Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection (2021) (6)
- Immunological responses in lymph nodes of the cat. (1970) (6)
- Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death (2016) (5)
- Recommendation for Using Smallpox Vaccine in a Pre-Event Vaccination Program : recommendations of the Advisory Committee on Immunization Practices (ACIP) (2003) (5)
- Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay. (2020) (5)
- Chemiluminescent microwell hybridization assay for direct detection of human parvovirus B19 DNA. (1994) (5)
- Strains of Respiratory Syncytial Virus: Implications for Vaccine Development (1991) (5)
- Paramyxoviridae: Respiratory Syncytial Virus (1988) (5)
- CX3CR1 Engagement by Respiratory Syncytial Virus Leads to Induction of Nucleolin and Dysregulation of Cilia-related Genes (2020) (4)
- Severe Acute Respiratory Syndrome: Peiris/Severe (2008) (4)
- PneumoniaCheck: A Device for Sampling Lower Airway Aerosols (2010) (4)
- Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis (2016) (4)
- Two RSV Platforms for G, F, or G+F Proteins VLPs (2020) (4)
- Waterborne Gastroenteritis duetotheNorwalk Agent: Clinical andEpidemiologic Investigation (1982) (4)
- Other Bat‐Borne Viruses (2015) (4)
- Antigenic and epi demiologic analysis of distinct strains of -respiratory syncytial virus from two successive community outbreaks 1983–1985 (1985) (4)
- A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion (2020) (3)
- Immunochemiluminescent Southern blot assay for polymerase chain reaction detection of human parvovirus B19 DNA. (1994) (3)
- Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays (2016) (3)
- The clinical spectrum of human parvovirus B19 infections. (1991) (3)
- UvA-DARE ( Digital Academic Repository ) Questions concerning the new haven coronavirus : letter (3)
- Purity, antigenicity and immunogenicity of the hepatitis B surface antigen purified by five different methods. (1988) (2)
- Sex-specific association between prenatal life stress exposure and infant pro-inflammatory cytokine levels during acute respiratory infection (2019) (2)
- Original antigenic sin responses to heterologous Betacoronavirus spike proteins are observed in mice following intramuscular administration, but are not apparent in children following SARS-CoV-2 infection (2021) (2)
- Human Parvovirus B19 (Preliminary Pages) (1997) (2)
- Identification and characterization of novel viruses (2008) (2)
- Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection (2020) (2)
- Kawasaki disease in a young adult. (1980) (2)
- Secretory Expression and Purification of Respiratory Syncytial Virus G and F Proteins in Human Cells. (2016) (2)
- Diarrheal Deaths in American Children (2017) (2)
- SARS Preparedness and Response Planning (2004) (2)
- Clinical experience with Wyeth Laboratories HDCS rabies vaccine at the Center for Disease Control. (1978) (1)
- Virus in the BALB/c Mouse Antibody Responses to Respiratory Syncytial CD40 Ligand (CD154) Enhances the Th1 and (2013) (1)
- Escaping an Epidemic (2005) (1)
- Synthetic LbL nanoparticle vaccines containing the chemokine mimic epitope of RSV-G protein and a CD8 epitope of RSV-M2 protein elicit broad-based cellular and humoral responses (155.7) (2011) (1)
- Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera (2021) (1)
- Rhinovirus-associated hospitalizations in young children. Commentary (2007) (1)
- Alaska Native Infants and the General United States Infant Population Respiratory Syncytial Virus Hospitalizations Among American Indian and (2005) (1)
- Detection ofEnterovirus 70withMonoclonal Antibodies (1984) (1)
- CX3CR1 Engagement by Respiratory Syncytial Virus Leads to Induction of Nucleolin and Dysregulation Cilia-Related Genes (2020) (0)
- An outbreak of pneumonia associated with emergent human adenovirus serotype 14 - Southeast Alaska, 2008 (2010) (0)
- Adenovirus 14: An Emerging Respiratory Pathogen (2008) (0)
- The family Adenoviridae includes a group of icosahedral nonenveloped viruses containing a double-stranded DNA (2010) (0)
- Differentiation ofRespiratory Syncytial VirusSubgroups withcDNA Probes inaNucleic AcidHybridization Assay (1990) (0)
- Textbook of human virology: Robert B. Belshe, Editor, 1984, Littleton, MA, PSG Publishing Co., Inc. (1986) (0)
- Preparing for a Possible Resurgence of SARS (2008) (0)
- Nosocomial Transmission ofRespiratory Syncytial Virusin Immunocompromised (1991) (0)
- Reemergence of Human Adenovirus 14 (2010) (0)
- Micrornas as biomarkers for determining respiratory syncytial virus disease pathogenesis and vaccine efficacy (2016) (0)
- Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing (2018) (0)
- Respiratory Syncytial Virus: Challenges and Opportunities for Prevention (2009) (0)
- Infected Patients Syncytial Virus Derived from B Cells of Treatment and Prophylaxis of Respiratory Potent High-Affinity Antibodies for (2009) (0)
- RESCEU WP2 data analysis meeting in Amsterdam (2018) (0)
- Ever-Changing World of Respiratory Tract Diseases (2009) (0)
- Diagnosis of Acute Respiratory Tract Infections in the Post-SARS Era (2004) (0)
- Correction, Vol. 10, No. 1 (2004) (0)
- immunoassay.virus proteins by competitive binding Identification of epitopes on respiratory (2013) (0)
- Antigenic and Genetic Diversity among the Attachment Proteins of Group A Respiratory Syncytial Viruses which have caused Repeat Infections in Children† 917 (1998) (0)
- Antigenic Characterization ofRespiratory Syncytial VirusGroupA andB Isolates inRiodeJaneiro, Brazil (1991) (0)
- The AIDS crisis and the medical-legal implications of transfusion therapy. (1991) (0)
- Novel Non-SARS Coronaviruses (2008) (0)
- Urine Levels of γ-Aminobutyric Acid are Associated with the Severity of Respiratory Syncytial Virus Infection in Infancy. (2020) (0)
- 1340. The Burden of Influenza and Rhinovirus Among Hospitalized Adults Post the COVID-19 Pandemic (2021) (0)
- Rabies diagnosis and rabies vaccine. (1979) (0)
- SerumImmunoglobulin A Response toNorwalkVirusInfection (1989) (0)
- Human parvoviruses. (1990) (0)
- 2314. Burden of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) (2019) (0)
- Immunoprophylaxis Use of Respiratory Syncytial Virus Surveillance Data to Optimize the Timing of (2010) (0)
- 1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) (2021) (0)
- Comprar Challenges And Opportunities For Respiratory Syncytial Virus Vaccines (Current Topics In Microbiology And Immunology, Vol. 372) | Anderson, L. | 9783642389184 | Springer (2013) (0)
- Detection of Human Parvovirus B19 DNA by polymerase chain reaction using labeled primer pairs and solid-phase enzyme immunoassay. (2000) (0)
- Appendix: Representative Compounds with Inhibitory Activity Against SARS CoV or Other CoVs in vitro (2005) (0)
- Identification oftheMajorStructural andNonstructural Proteins Encoded byHumanParvovirus B19andMapping ofTheir Genesby Procaryotic Expression ofIsolated GenomicFragments (1986) (0)
This paper list is powered by the following services:
Other Resources About Larry J. Anderson
What Schools Are Affiliated With Larry J. Anderson?
Larry J. Anderson is affiliated with the following schools:
